J. David Enloe Jr - Dec 15, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Executive Officer, Director
Signature
By: Ryan D. Lake, attorney- in-fact
Stock symbol
SCTL
Transactions as of
Dec 15, 2021
Transactions value $
$993
Form type
4
Date filed
12/17/2021, 06:37 PM
Previous filing
Nov 16, 2021
Next filing
Jan 19, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Purchase $993 +617 +0.4% $1.61 154K Dec 15, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.